Back

Pilot Randomized Trial of Intermittent Theta-Burst Stimulation versus H-Coil Transcranial Magnetic Stimulation for Treatment-Resistant Depression

Desbeaumes Jodoin, V.; Bousseau, E.; Trottier-Duclos, F.; Jutras-Aswad, D.; Lesperance, F.; Nguyen, D. K.; Bou Assi, E.; Blumberger, D. M.; Arns, M.; Bakert, T. E.; Daskalakis, Z.; Lesperance, P.; Miron, J.-P.

2026-03-16 psychiatry and clinical psychology
10.64898/2026.03.13.26348335 medRxiv
Show abstract

BackgroundIntermittent theta burst stimulation (iTBS) and H-coil repetitive transcranial magnetic stimulation (rTMS) are FDA-cleared treatments for major depression; yet their comparative effectiveness in treatment-resistant depression (TRD) has not been evaluated in randomized trials. This pilot randomized trial was designed to obtain preliminary comparative estimates and to explore whether baseline cognitive functioning relates to early remission. MethodsTwenty-eight adults with TRD were randomized to six weeks of iTBS delivered to the dorsolateral prefrontal cortex (DLPFC) using a figure-8 coil (n=15) or H-coil rTMS delivered to the dorsomedial prefrontal cortex (DMPFC) using a H7-coil (n=13). The primary outcome was change in 17-item Hamilton Depression Rating Scale (HRSD-17) score from baseline to week 6, analyzed with ANCOVA. Additional outcomes included response, remission, and symptom trajectories through week 18. Exploratory analyses examined the association between baseline cognitive functioning, such as executive functions and memory, and remission. ResultsTwenty-five participants completed all 30 sessions. Adjusted week-6 HRSD-17 scores did not differ between groups (mean difference -0.40, 95% CI -5.23 to 4.43; p=.865). Response rates were 40.0% for iTBS and 50.0% for H-coil (p>.60), and remission rates were identical across groups (20.0%). Remitters showed higher baseline executive functioning than non-remitters in exploratory analyses, although these associations were not confirmed in adjusted models. ConclusionIn this pilot trial, iTBS and H7-coil rTMS showed symptom improvement, with no clear between-group pattern. Exploratory findings suggest a potential signal involving executive functioning that warrants further investigation. These results inform the feasibility and design of larger comparative trials. Trial registrationClinicalTrials.gov (NCT05902312)

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Journal of Affective Disorders
81 papers in training set
Top 0.1%
16.7%
2
Journal of Psychiatric Research
28 papers in training set
Top 0.1%
8.0%
3
Brain Stimulation
112 papers in training set
Top 0.4%
6.0%
4
Psychological Medicine
74 papers in training set
Top 0.3%
6.0%
5
Journal of Neurology, Neurosurgery & Psychiatry
29 papers in training set
Top 0.2%
4.1%
6
European Psychiatry
10 papers in training set
Top 0.1%
4.1%
7
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.5%
3.4%
8
Biological Psychiatry
119 papers in training set
Top 1%
3.4%
50% of probability mass above
9
European Neuropsychopharmacology
15 papers in training set
Top 0.1%
3.4%
10
Translational Psychiatry
219 papers in training set
Top 2%
2.9%
11
PLOS ONE
4510 papers in training set
Top 43%
2.9%
12
Molecular Psychiatry
242 papers in training set
Top 1%
2.8%
13
Journal of Psychopharmacology
14 papers in training set
Top 0.2%
2.3%
14
JAMA Network Open
127 papers in training set
Top 1%
2.3%
15
Frontiers in Psychiatry
83 papers in training set
Top 2%
2.0%
16
Journal of Affective Disorders Reports
10 papers in training set
Top 0.1%
2.0%
17
Neuropsychopharmacology
134 papers in training set
Top 1%
1.8%
18
BMJ Mental Health
15 papers in training set
Top 0.1%
1.8%
19
JAMA Psychiatry
13 papers in training set
Top 0.2%
1.7%
20
Acta Neuropsychiatrica
12 papers in training set
Top 0.5%
1.6%
21
Psychiatry Research
35 papers in training set
Top 1.0%
1.6%
22
BMC Medicine
163 papers in training set
Top 4%
1.4%
23
Biological Psychiatry Global Open Science
54 papers in training set
Top 1.0%
1.2%
24
PLOS Medicine
98 papers in training set
Top 3%
1.2%
25
The British Journal of Psychiatry
21 papers in training set
Top 0.8%
0.9%
26
Nature Communications
4913 papers in training set
Top 59%
0.9%
27
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.1%
0.9%
28
Psychopharmacology
59 papers in training set
Top 0.6%
0.9%
29
Brain, Behavior, and Immunity
105 papers in training set
Top 2%
0.9%
30
Acta Psychiatrica Scandinavica
10 papers in training set
Top 0.5%
0.7%